Chiaki Isobe

Morioka, 0200805, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Decrease in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in cerebrospinal fluid during elderly aging and in patients with sporadic form of amyotrophic lateral sclerosis.

Decrease in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in cerebrospinal fluid during elderly aging and in patients with sporadic form of amyotrophic lateral sclerosis.

Journal: Neuro-Signals

Published: November 18, 2009

Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process.

Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process.

Journal: Neuroscience letters

Published: October 09, 2009

L-Dopa therapy increases homocysteine concentration in cerebrospinal fluid from patients with Parkinson's disease.

L-Dopa therapy increases homocysteine concentration in cerebrospinal fluid from patients with Parkinson's disease.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia

Published: September 25, 2009

Increase in the oxidized/total coenzyme Q-10 ratio in the cerebrospinal fluid of Alzheimer's disease patients.

Increase in the oxidized/total coenzyme Q-10 ratio in the cerebrospinal fluid of Alzheimer's disease patients.

Journal: Dementia and geriatric cognitive disorders

Published: September 23, 2009

Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the CSF of patients with Alzheimer's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process.

Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the CSF of patients with Alzheimer's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process.

Journal: Journal of neurology

Published: July 14, 2009

Remarkable increase in 3-nitrotyrosine in the cerebrospinal fluid in patients with lacunar stroke.

Remarkable increase in 3-nitrotyrosine in the cerebrospinal fluid in patients with lacunar stroke.

Journal: Brain research

Published: July 02, 2009

Homocysteine may contribute to pathogenesis of RNA damage in brains with Alzheimer's disease.

Homocysteine may contribute to pathogenesis of RNA damage in brains with Alzheimer's disease.

Journal: Neuro-degenerative diseases

Published: February 15, 2009

Cabergoline scavenges peroxynitrite enhanced by L-DOPA therapy in patients with Parkinson's disease.

Cabergoline scavenges peroxynitrite enhanced by L-DOPA therapy in patients with Parkinson's disease.

Journal: European journal of neurology

Published: April 29, 2006

Increase of oxidized/total coenzyme Q-10 ratio in cerebrospinal fluid in patients with Parkinson's disease.

Increase of oxidized/total coenzyme Q-10 ratio in cerebrospinal fluid in patients with Parkinson's disease.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia

Published: October 15, 2005

Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease.

Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease.

Journal: Life sciences

Published: October 22, 2004

Showing 1-10 of 10

Last Updated: 09/26/2026